reboxetine has been researched along with topiramate in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (topiramate) | Trials (topiramate) | Recent Studies (post-2010) (topiramate) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 3,197 | 557 | 1,329 |
| Protein | Taxonomy | reboxetine (IC50) | topiramate (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 0.25 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.8683 | |
| Carbonic anhydrase 2 | Rattus norvegicus (Norway rat) | 1.4 | |
| Carbonic anhydrase 4 | Bos taurus (cattle) | 0.054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH | 1 |
1 review(s) available for reboxetine and topiramate
| Article | Year |
|---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Nizatidine; Ranitidine; Reboxetine; Schizophrenia; Topiramate; Weight Gain | 2022 |